Renub

    Press Release:

    China Cancer Test Market will be US$ 24 Billion by 2022 due to Rising Cancer cases & Innovation in Technology

    China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022

    Excel: 4 Hours
    PDF: 4 Hours
    Aug 2017
    Pages: 357

     

    Renub Research report titled “China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022” studies the oncology market in China.

    Get 10% Free Customization in this Report

    As per Renub Research analysis China Cancer Test Market is projected to cross US$ 24 Billion by the end of 2022. In China, cancer cases are rising and are one of the major causes of deaths in urban and rural areas. In order to mitigate cancer prevalence in China; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and treatment. Early diagnosis programs include screening for breast and cervix cancer while prevention programs such as anti-smoking campaigns and immunization against hepatitis. Public awareness against cancer and the promotion of healthy lifestyle have also been carried out actively. 

     

    Request a free sample copy of the report: http://www.renub.com/contactus.php


    Growing Lung Cancer out of 26 Cancer Cases Studied in the Report

    Cancer is one of the most significant public health burdens in China. China has exceptional number of lung cancer diagnoses and deaths than any other part of the world. The problem will keep mounting in near future as China’ air pollution goes mostly unchecked. In total 26 types of Cancer market and number of cases have been studied in the report.  

    Lung Cancer dominates the China Oncology (Cancer) Screening Tests Market and Volume

    In Male: Lung Cancer is the most predominant cancer, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order). 

    In Female: Other than Lung, Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma. 


    High Cancer Mortality Rates

    Cancer mortality rates in China have been rising rapidly over the past three decades. In urban region, the mortality of cancer is comparatively higher than in rural one. Out of 26 Types of Cancer studied in the report, Lung cancer accounts for the highest fatalities, followed by Digestive Tract Cancers (Stomach, Liver Cancer, Esophageal and Colorectum Cancer).

    This 357 page report with 314 Figures and 12 Tables provides in-depth analysis of China Cancer Tests Market and Volume. All 26 types of cancer in the report have been analyzed from 3 major viewpoints which further study it from 2 different perspectives.

    1.    China Cancer (Oncology) Screening Tests Market & Forecast

    •    Male
    •    Female

    2.    China Cancer (Oncology) Screening Tests Volume & Forecast

    •    Male
    •    Female

    3.    China Cancer (Oncology) Mortality Rate


    All the 26 Cancer Market & Cases Studied in the Report are as Follows: 

    1.    Lip, oral cavity, & pharynx (except nasopharynx)
    2.    Nasopharynx
    3.    Esophagus
    4.    Stomach
    5.    Colorectum
    6.    Liver
    7.    Gallbladder
    8.    Pancreas
    9.    Larynx
    10.    Lung
    11.    Other thoracic organs
    12.    Bone
    13.    Melanoma of the skin
    14.    Breast
    15.    Cervix
    16.    Uterus
    17.    Ovary
    18.    Prostate
    19.    Testis
    20.    Kidney
    21.    Bladder
    22.    Brain, CNS
    23.    Thyroid
    24.    Lymphoma
    25.    Leukemia
    26.    All other sites and unspecified

     

    1.    Research Findings

    2.    China – Cancer Test Market (2010 – 2022)
    2.1    Male – Cancer Test Market & Forecast

    2.2    Female – Cancer Test Market & Forecast

    3.    China – Cancer Test Volume (2010 – 2022)
    3.1    Male – Cancer Test Volume & Forecast

    3.2    Female – Cancer Test Volume & Forecast

    4.    China – Cancer Test Market Share (2010 – 2022)
    4.1    Male – Cancer Test Market Share & Forecast

    4.2    Female – Cancer Test Market Share & Forecast

    5.    China Oncology Test Market Share - Male Vs Female

    6.    China – Cancer Test Volume Share (2010 – 2022)
    6.1    Male – Cancer Test Volume Share & Forecast

    6.2    Female – Cancer Test Volume Share & Forecast

    7.    China Oncology Test Volume Share - Male Vs Female

    8.    China – Cancer Test Market (2010 – 2022)
    8.1    Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market & Forecast
    8.1.1    Male – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market
    8.1.2    Female – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market

    8.2    Nasopharynx Cancer Test Market & Forecast
    8.2.1    Male – Nasopharynx Cancer Test Market
    8.2.2    Female – Nasopharynx Cancer Test Market

    8.3    Esophagus Cancer Test Market & Forecast
    8.3.1    Male – Esophagus Cancer Test Market
    8.3.2    Female – Esophagus Cancer Test Market

    8.4    Stomach Cancer Test Market & Forecast
    8.4.1    Male – Stomach Cancer Test Market
    8.4.2    Female – Stomach Cancer Test Market

    8.5    Colorectum Cancer Test Market
    8.5.1    Male – Colorectum Cancer Test Market
    8.5.2    Female – Colorectum Cancer Test Market

    8.6    Liver Cancer Test Market & Forecast
    8.6.1    Male – Liver Cancer Test Market
    8.6.2    Female – Liver Cancer Test Market

    8.7    Gallbladder Cancer Test Market & Forecast
    8.7.1    Male – Gallbladder Cancer Test Market
    8.7.2    Female – Gallbladder Cancer Test Market

    8.8    Pancreas Cancer Test Market & Forecast
    8.8.1    Male – Pancreas Cancer Test Market
    8.8.2    Female – Pancreas Cancer Test Market

    8.9    Larynx Cancer Test Market & Forecast
    8.9.1    Male – Larynx Cancer Test Market
    8.9.2    Female – Larynx Cancer Test Market

    8.10    Lung Cancer Test Market & Forecast
    8.10.1    Male – Lung Cancer Test Market
    8.10.2    Female – Lung Cancer Test Market

    8.11    Other Thoracic Organs Cancer Test Market & Forecast
    8.11.1    Male – Other Thoracic Organs Cancer Test Market
    8.11.2    Female – Other Thoracic Organs Cancer Test Market

    8.12    Bone Cancer Test Market & Forecast
    8.12.1    Male – Bone Cancer Test Market
    8.12.2    Female – Bone Cancer Test Market

    8.13    Melanoma Skin Cancer Test Market & Forecast
    8.13.1    Male – Melanoma Skin Cancer Test Market
    8.13.2    Female – Melanoma Skin Cancer Test Market

    8.14    Breast Cancer Test Market & Forecast
    8.14.1    Male – Breast Cancer Test Market
    8.14.2    Female – Breast Cancer Test Market

    8.15    Cervix Cancer Test Market & Forecast

    8.16    Uterus Cancer Test Market & Forecast

    8.17    Ovary Cancer Test Market & Forecast

    8.18    Prostate Cancer Test Market & Forecast

    8.19    Testis Cancer Test Market

    8.20    Kidney Cancer Test Market & Forecast
    8.20.1    Male – Kidney Cancer Test Market
    8.20.2    Female – Kidney Cancer Test Market

    8.21    Bladder Cancer Test Market & Forecast
    8.21.1    Male – Bladder Cancer Test Market
    8.21.2    Female – Bladder Test Market

    8.22    Brain, CNS Cancer Test Market & Forecast
    8.22.1    Male – Brain, CNS Cancer Test Market
    8.22.2    Female – Brain, CNS Cancer Test Market

    8.23    Thyroid Cancer Test Market & Forecast
    8.23.1    Male – Thyroid Cancer Test Market
    8.23.2    Female – Thyroid Cancer Test Market

    8.24    Lymphoma Cancer Test Market
    8.24.1    Male – Lymphoma Cancer Test Market
    8.24.2    Female – Lymphoma Cancer Test Market

    8.25    Leukemia Cancer Test Market
    8.25.1    Male – Leukemia Cancer Test Market
    8.25.2    Female – Leukemia Cancer Test Market

    8.26    All Other and Unspecified Test Market
    8.26.1    Male – All Other and Unspecified Cancer Test Market
    8.26.2    Female – All Other and Unspecified Cancer Test Market

    9.    China – Oncology Test Volume (2010 – 2022)
    9.1    Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume
    9.1.1    Male – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume
    9.1.2    Female – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume

    9.2    Nasopharynx Cancer Test Volume
    9.2.1    Male – Nasopharynx Cancer Test Volume
    9.2.2    Female – Nasopharynx Cancer Test Volume

    9.3    Esophagus Cancer Test Volume
    9.3.1    Male – Esophagus Cancer Test Volume
    9.3.2    Female – Esophagus Cancer Test Volume

    9.4    Stomach Cancer Test Volume
    9.4.1    Male – Stomach Cancer Test Volume
    9.4.2    Female – Stomach Cancer Test Volume

    9.5    Colorectum Cancer Test Volume
    9.5.1    Male – Colorectum Cancer Test Volume
    9.5.2    Female – Colorectum Cancer Test Volume

    9.6    Liver Cancer Test Volume
    9.6.1    Male – Liver Cancer Test Volume
    9.6.2    Female – Liver Cancer Test Volume

    9.7    Gallbladder Cancer Test Volume
    9.7.1    Male – Gallbladder Cancer Test Volume
    9.7.2    Female – Gallbladder Cancer Test Volume

    9.8    Pancreas Cancer Test Volume
    9.8.1    Male – Pancreas Cancer Test Volume
    9.8.2    Female – Pancreas Cancer Test Volume

    9.9    Larynx Cancer Test Volume
    9.9.1    Male – Larynx Cancer Test Volume
    9.9.2    Female – Larynx Cancer Test Volume

    9.10    Lung Cancer Test Volume
    9.10.1    Male – Lung Cancer Test Volume
    9.10.2    Female – Lung Cancer Test Volume

    9.11    Other Thoracic Organs Test Volume
    9.11.1    Male – Other Thoracic Organs Cancer Test Volume
    9.11.2    Female – Other Thoracic Organs Cancer Test Volume

    9.12    Bone Cancer Test Volume
    9.12.1    Male – Bone Cancer Test Volume
    9.12.2    Female – Bone Cancer Test Volume

    9.13    Melanoma of the Skin Cancer Test Volume
    9.13.1    Male – Melanoma of the Skin Cancer Test Volume
    9.13.2    Female – Melanoma of the Skin Cancer Test Volume

    9.14    Breast Cancer Test Volume
    9.14.1    Male – Breast Cancer Test Volume
    9.14.2    Female – Breast Cancer Test Volume

    9.15    Cervix Cancer Test Volume

    9.16    Uterus Cancer Test Volume

    9.17    Ovary Cancer Test Volume

    9.18    Prostate Cancer Test Volume

    9.19    Testis Cancer Test Volume

    9.20    Kidney Cancer Test Volume
    9.20.1    Male – Kidney Cancer Test Volume
    9.20.2    Female – Kidney Cancer Test Volume

    9.21    Bladder Cancer Test Volume
    9.21.1    Male – Bladder Cancer Test Volume
    9.21.2    Female – Bladder Cancer Test Volume

    9.22    Brain, CNS Cancer Test Volume
    9.22.1    Male – Brain, CNS Cancer Test Volume
    9.22.2    Female – Brain, CNS Cancer Test Volume

    9.23    Thyroid Cancer Test Volume
    9.23.1    Male – Thyroid Cancer Test Volume
    9.23.2    Female – Thyroid Cancer Test Volume

    9.24    Lymphoma Cancer Test Volume
    9.24.1    Male – Lymphoma Cancer Test Volume
    9.24.2    Female – Lymphoma Cancer Test Volume

    9.25    Leukemia Cancer Test Volume
    9.25.1    Male – Leukemia Cancer Test Volume
    9.25.2    Female – Leukemia Cancer Test Volume

    9.26    All Other and Unspecified Test Volume
    9.26.1    Male – All Other and Unspecified Cancer Test Volume
    9.26.2    Female – All Other and Unspecified Cancer Test Volume

    10.    China – Cancer Deaths (2010 – 2022)

    11.    China – Cancer Mortality Rate (2015)
    11.1    Lip, Oral Cavity, & Pharynx (except Nasopharynx)

    11.2    Nasopharynx

    11.3    Esophagus

    11.4    Stomach

    11.5    Colorectum

    11.6    Liver

    11.7    Gallbladder

    11.8    Pancreas

    11.9    Larynx

    11.10    Lung

    11.11    Other Thoracic Organs

    11.12    Bone

    11.13    Melanoma of the skin

    11.14    Breast

    11.15    Cervix

    11.16    Uterus

    11.17    Ovary

    11.18    Prostate

    11.19    Testis

    11.20    Kidney

    11.21    Bladder

    11.22    Brain, CNS

    11.23    Thyroid

    11.24    Lymphoma

    11.25    Leukemia

    11.26    All Other and Unspecified

    12.    China Healthcare Policies and Reimbursement
    12.1 Healthcare Policies

    12.2    China Healthcare Insurance Schemes
    12.2.1    NRCMS
    12.2.2    UEBMI
    12.2.3    URBMI
    12.2.4    Private Health Insurance

    13.    Appendix
     

    List of Figures

    Figure 2‑1: China – Cancer Test Market (Billion US$), 2010 - 2016
    Figure 2‑2: China – Forecast for Oncology Test Market (Billion US$), 2017 - 2022
    Figure 2‑3: China – Cancer (Male) Test Market (Billion US$), 2010 - 2016
    Figure 2‑4: China – Forecast for Cancer (Male) Test Market (Billion US$), 2017 - 2022
    Figure 2‑5: China – Cancer (Female) Test Market (Billion US$), 2010 - 2016
    Figure 2‑6: China – Forecast for Cancer (Female) Test Market (Billion US$), 2017 - 2022

    Figure 3‑1: China – Cancer Test Volume (Million), 2010 - 2016
    Figure 3‑2: China – Forecast for Cancer Test Volume (Million), 2017 - 2022
    Figure 3‑3: China – Oncology (Male) Test Volume (Million), 2010 - 2016
    Figure 3‑4: China – Forecast for Oncology (Male) Test Volume (Million), 2017 - 2022
    Figure 3‑5: China – Oncology (Female) Test Volume (Million), 2010 - 2016
    Figure 3‑6: China – Forecast for Oncology (Female) Test Volume (Million), 2017 - 2022

    Figure 5‑1: China Cancer Test Market Share (%) - Male Vs Female, 2016 - 2022

    Figure 7‑1: China Cancer Test Volume Share (%) - Male Vs Female, 2016 - 2022

    Figure 8‑1: China – Lip, oral cavity, & pharynx (except nasopharynx) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑2: China – Forecast for Lip, oral cavity, & pharynx (except nasopharynx) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑3: China – Lip, oral cavity, & pharynx (except nasopharynx) (Male) Test Market (Million US$), 2010 - 2016
    Figure 8‑4: China – Forecast for Lip, oral cavity, & pharynx (except nasopharynx) (Male) Test Market (Million US$), 2017 - 2022
    Figure 8‑5: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑6: China – Forecast for Lip, oral cavity, & pharynx (except nasopharynx) (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑7: China – Nasopharynx Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑8: China – Forecast for Nasopharynx Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑9: China – Nasopharynx (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑10: China – Forecast for Nasopharynx (Male)  Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑11: China – Nasopharynx (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑12: China – Forecast for Nasopharynx (Female) Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑13: China – Esophagus Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑14: China – Forecast for Esophagus Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑15: China – Esophagus (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑16: China – Forecast for Esophagus (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑17: China – Esophagus (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑18: China – Forecast For Esophagus (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑19: China – Stomach Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑20: China – Forecast for Stomach Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑21: China – Stomach (Male) Test Market (Million US$), 2010 - 2016
    Figure 8‑22: China – Forecast for Stomach (Male) Test Market (Million US$), 2017 - 2022
    Figure 8‑23: China – Stomach (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑24: China – Forecast for Stomach (Female) Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑25: China – Colorectum Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑26: China – Forecast for Colorectum Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑27: China – Colorectum (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑28: China – Forecast for Colorectum (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑29: China – Colorectum (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑30: China – Forecast for Colorectum (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑31: China – Liver Cancer Test Market (Million US$), 2010 – 2016
    Figure 8‑32: China – Forecast for Liver Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑33: China – Liver (Male) Test Market (Million US$), 2010 - 2016
    Figure 8‑34: China – Forecast for Liver (Male) Test Market (Million US$), 2017 - 2022
    Figure 8‑35: China – Liver (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑36: China – Forecast for Liver (Female) Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑37: China – Gallbladder Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑38: China – Forecast for Gallbladder Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑39: China – Gallbladder (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑40: China – Forecast for Gallbladder (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑41: China – Gallbladder (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑42: China – Forecast for Gallbladder (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑43: China – Pancreas Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑44: China – Forecast for Pancreas Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑45: China – Pancreas (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑46: China – Forecast for Pancreas (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑47: China – Pancreas (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑48: China – Forecast for Pancreas (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑49: China – Larynx Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑50: China – Forecast for Larynx Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑51: China – Larynx (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑52: China – Forecast for Larynx (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑53: China – Larynx (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑54: China – Forecast for Larynx (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑55: China – Lung Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑56: China – Forecast for Lung Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑57: China – Lung (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑58: China – Forecast for Lung (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑59: China – Lung (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑60: China – Forecast for Lung (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑61: China – Other Thoracic Organs Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑62: China – Forecast for Other Thoracic Organs Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑63: China – Other Thoracic Organs (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑64: China – Forecast for Other Thoracic Organs (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑65: China – Other thoracic organs (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑66: China – Forecast for Other thoracic organs (Female) Test Market (Million US$), 2017 - 2022
    Figure 8‑67: China – Bone Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑68: China – Forecast for Bone Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑69: China – Bone (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑70: China – Forecast for Bone (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑71: China – Bone (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑72: China – Forecast for Bone (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑73: China – Melanoma of the Skin Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑74: China – Forecast for Melanoma of the Skin Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑75: China – Melanoma Skin Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑76: China – Forecast for Melanoma Skin Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑77: China – Melanoma Skin (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑78: China – Forecast for Melanoma of Skin (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑79: China – Breast Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑80: China – Forecast for Breast Test Market (Million US$), 2017 - 2022
    Figure 8‑81: China – Breast (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑82: China – Forecast for Breast (Male) Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑83: China – Breast (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑84: China – Forecast for Breast (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑85: China – Cervix Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑86: China – Forecast for Cervix Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑87: China – Uterus Test Market (Million US$), 2010 - 2016
    Figure 8‑88: China – Forecast for Uterus Test Market (Million US$), 2017 - 2022
    Figure 8‑89: China – Ovary Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑90: China – Forecast for Ovary Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑91: China – Prostate Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑92: China – Forecast for Prostate Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑93: China – Testis Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑94: China – Forecast for Testis Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑95: China – Kidney Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑96: China – Forecast for Kidney Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑97: China – Kidney (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑98: China – Forecast for Kidney (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑99: China – Kidney (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑100: China – Forecast for Kidney (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑101: China – Bladder Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑102: China – Forecast for Bladder Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑103: China – Bladder (Male) Test Market (Million US$), 2010 - 2016
    Figure 8‑104: China – Forecast for Bladder (Male) Test Market (Million US$), 2017 - 2022
    Figure 8‑105: China – Bladder (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑106: China – Forecast for Bladder (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑107: China – Brain, CNS Test Market (Million US$), 2010 - 2016
    Figure 8‑108: China – Forecast for Brain, CNS Test Market (Million US$), 2017 - 2022
    Figure 8‑109: China – Brain, CNS (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑110: China – Forecast for Brain, CNS (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑111: China – Brain, CNS (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑112: China – Forecast for Brain, CNS (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑113: China – Thyroid Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑114: China – Forecast for Thyroid Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑115: China – Thyroid (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑116: China – Forecast for Thyroid (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑117: China – Thyroid (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑118: China – Forecast for Thyroid (Female) Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑119: China – Lymphoma Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑120: China – Forecast for Lymphoma Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑121: China – Lymphoma (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑122: China – Forecast for Lymphoma (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑123: China – Lymphoma (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑124: China – Forecast for Lymphoma (Female) Cancer Test Market (Million US$), 2017 – 2022
    Figure 8‑125: China – Leukemia Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑126: China – Forecast for Leukemia Test Market (Million US$), 2017 - 2022
    Figure 8‑127: China – Leukemia (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑128: China – Forecast for Leukemia (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑129: China – Leukemia (Female) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑130: China – Forecast for Leukemia (Female) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑131: China – All Other and Unspecified Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑132: China – Forecast for All Other and Unspecified Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑133: China – All Other and Unspecified (Male) Cancer Test Market (Million US$), 2010 - 2016
    Figure 8‑134: China – Forecast for All Other and Unspecified (Male) Cancer Test Market (Million US$), 2017 - 2022
    Figure 8‑135: China – All Other and Unspecified (Female) Cancer Test Market (Million US$), 2010 – 2016
    Figure 8‑136: China – Forecast for All Other and Unspecified (Female) Cancer Test Market (Million US$), 2017 – 2022

    Figure 9‑1: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑2: China – Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑3: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑4: China – Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑5: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑6: China – Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑7: China – Nasopharynx Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑8: China – Forecast for Nasopharynx Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑9: China – Nasopharynx (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑10: China – Forecast for Nasopharynx (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑11: China – Nasopharynx (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑12: China – Forecast for Nasopharynx (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑13: China – Esophagus Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑14: China – Forecast for Esophagus Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑15: China – Esophagus (Male) Cancer Test Volume (Thousand), 2010 -2016
    Figure 9‑16: China – Forecast for Esophagus (Male) Cancer Test Volume (Thousand), 2017 -2022
    Figure 9‑17: China – Esophagus (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑18: China – Forecast for Esophagus (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑19: China – Stomach Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑20: China – Forecast for Stomach Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑21: China – Stomach (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑22: China – Forecast for Stomach (Male) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑23: China – Stomach (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑24: China – Stomach (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑25: China – Colorectum Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑26: China – Forecast for Colorectum Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑27: China – Colorectum (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑28: China – Forecast for Colorectum (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑29: China – Colorectum (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑30: China – Forecast for Colorectum (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑31: China – Liver Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑32: China – Forecast for Liver Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑33: China – Liver (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑34: China – Forecast for Liver (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑35: China – Liver (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑36: China – Forecast for Liver (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑37: China – Gallbladder Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑38: China – Forecast for Gallbladder Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑39: China – Gallbladder (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑40: China – Forecast for Gallbladder (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑41: China – Gallbladder (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑42: China – Forecast for Gallbladder (Female) Test Volume (Thousand), 2017 – 2022
    Figure 9‑43: China – Pancreas Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑44: China – Forecast for Pancreas Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑45: China – Pancreas (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑46: China – Forecast for Pancreas (Male) Test Volume (Thousand), 2017 - 2022
    Figure 9‑47: China – Pancreas (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑48: China – Forecast for Pancreas (Female) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑49: China – Larynx Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑50: China – Forecast for Larynx Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑51: China – Larynx (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑52: China – Forecast for Larynx (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑53: China – Larynx (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑54: China – Forecast for Larynx (Female) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑55: China – Lung Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑56: China – Forecast for Lung Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑57: China – Lung (Male) Cacner Test Volume (Thousand), 2010 - 2016
    Figure 9‑58: China – Forecast for Lung (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑59: China – Lung (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑60: China – Forecast for Lung (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑61: China – Other Thoracic Organs Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑62: China – Forecast for Other Thoracic Organs Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑63: China – Other Thoracic Organs (Male) Cancer Test Volume (Thousand), 2010 – 2016
    Figure 9‑64: China – Forecast for Other Thoracic Organs (Male) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑65: China – Other Thoracic Organs (Female) Cancer Test Volume (Thousand), 2010 – 2016
    Figure 9‑66: China – Forecast for Other thoracic organs (Female) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑67: China – Bone Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑68: China – Forecast for Bone Test Volume (Thousand), 2017 - 2022
    Figure 9‑69: China – Bone (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑70: China – Forecast for Bone (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑71: China – Bone (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑72: China – Forecast for Bone (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑73: China – Melanoma of the Skin Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑74: China – Forecast for Melanoma of the Skin Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑75: China – Melanoma of the Skin (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑76: China – Forecast for Melanoma of the skin (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑77: China – Melanoma of the Skin (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑78: China – Melanoma of the Skin (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑79: China – Breast Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑80: China – Forecast for Breast Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑81: China – Breast (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑82: China – Forecast for Breast (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑83: China – Breast (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑84: China – Forecast for Breast (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑85: China – Cervix Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑86: China – Forecast for Cervix Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑87: China – Uterus Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑88: China – Forecast for Uterus Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑89: China – Ovary Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑90: China – Forecast for Ovary Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑91: China – Prostate Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑92: China – Forecast for Prostate Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑93: China – Testis Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑94: China – Forecast for Testis Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑95: China – Kidney Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑96: China – Forecast for Kidney Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑97: China – Kidney (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑98: China – Forecast for Kidney (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑99: China – Kidney (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑100: China – Forecast for Kidney (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑101: China – Bladder Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑102: China – Forecast for Bladder Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑103: China – Bladder (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑104: China – Forecast for Bladder (Male) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑105: China – Bladder (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑106: China – Forecast for Bladder (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑107: China – Brain, CNS Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑108: China – Forecast for Brain, CNS Test Volume (Thousand), 2017 - 2022
    Figure 9‑109: China – Brain, CNS (Male) Cancer Test Volume (Thousand), 2010 – 2016
    Figure 9‑110: China – Forecast for Brain, CNS (Male) Test Volume (thousand), 2017 – 2022
    Figure 9‑111: China – Brain, CNS (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑112: China – Forecast for Brain, CNS (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑113: China – Thyroid Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑114: China – Forecast for Thyroid Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑115: China – Thyroid (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑116: China – Forecast for Thyroid (Male) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑117: China – Thyroid (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑118: China – Forecast for Thyroid (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑119: China – Lymphoma Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑120: China – Forecast for Lymphoma Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑121: China – Lymphoma (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑122: China – Forecast for Lymphoma (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑123: China – Lymphoma (Female) Cancer Test Volume (Thousand), 2010 – 2016
    Figure 9‑124: China – Forecast for Lymphoma (Female) Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑125: China – Leukemia Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑126: China – Forecast for Leukemia Cancer Test Volume (Thousand), 2017 – 2022
    Figure 9‑127: China – Leukemia (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑128: China – Forecast for Leukemia (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑129: China – Leukemia (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑130: China – Forecast for Leukemia (Female) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑131: China – All Other and Unspecified Caner Test Volume (Thousand), 2010 - 2016
    Figure 9‑132: China – Forecast for All Other and Unspecified Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑133: China – All Other and Unspecified (Male) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑134: China – Forecast for All Other and Unspecified (Male) Cancer Test Volume (Thousand), 2017 - 2022
    Figure 9‑135: China – All other and unspecified (Female) Cancer Test Volume (Thousand), 2010 - 2016
    Figure 9‑136: China – Forecast for All Other and Unspecified (Female) Cancer Test Volume (Thousand), 2017 - 2022

    Figure 10‑1: China – Cancer Deaths (Million), 2010 - 2016
    Figure 10‑2: China – Estimation for Cancer Deaths (Million), 2017 – 2022

    Figure 11‑1: Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑2: Nasopharynx Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑3: Esophagus Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑4: Stomach Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑5: Colorectum Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑6: Liver Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑7: Gallbladder Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑8: Pancreas Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑9: Larynx Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑10: Lung Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑11: Other Thoracic Organs Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑12: Bone Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑13: Melanoma of the skin Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑14: Breast Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑15: Cervix Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑16: Uterus Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑17: Ovary Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑18: Prostate Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑19: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑20: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑21: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑22: Brain, CNS Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑23: Thyroid Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑24: Lymphoma Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑25: Leukemia Cancer Mortality Rate (Thousand) By Sex, 2015
    Figure 11‑26: All other and unspecified Cancer Mortality Rate (Thousand) By Sex, 2015

     

    List of Tables

    Table 4‑1: China – Cancer Test Market Share (%), 2010 - 2016
    Table 4‑2: China – Forecast for Cancer Test Market Share (%), 2017 - 2022
    Table 4‑3: China – Oncology (Male) Test Market Share (%), 2010 - 2016
    Table 4‑4: China – Forecast for Oncology (Male) Test Market Share (%), 2017 - 2022
    Table 4‑5: China – Cancer (Female) Test Market Share (%), 2010 - 2016
    Table 4‑6: China – Forecast for Cancer (Female) Test Market Share (%), 2017 - 2022

    Table 6‑1: China – Cancer Test Volume Share (%), 2010 - 2016
    Table 6‑2: China – Forecast for Cancer Test Volume Share (%), 2017 - 2022
    Table 6‑3: China – Cancer (Male) Test Volume Share (%), 2010 - 2016
    Table 6‑4: China – Forecast for Cancer (Male) Test Volume Share (%), 2017 - 2022
    Table 6‑5: China – Cancer (Female) Test Volume Share (%), 2010 - 2016
    Table 6‑6: China – Forecast for Cancer (Female) Test Volume Share (%), 2017 – 2022

    Related Reports

    • China In–Vitro Diagnostics (IVD) Market, By Diagnostics (Immunoassay, Microbiology, Molecular, SMBG, POCT & etc.) & Companies

      China In–Vitro Diagnostics (IVD) Market is projected to exceed US$ 12 Billion by the end of year 2024. China In–Vitro Diagnostics (IVD) Market is growing significantly and is expected to continue its ongoing trend during the forecast period as well, owing to rapidly increasing middle class population who is now willing to pay more for better healthcare services and aging population who are more vulnerable to contagious diseases. Also, Chinese aging population is experiencing an outburst of c...

      Price: $1,490.00
      Sample
      Buy Now

    • Point of Care Testing Market, Global Forecast, by Diagnostics, Mode, End Users, Regions & Companies

      Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created ...

      Price: $1,590.00
      Sample
      Buy Now

    About Renub

    Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting.

    Connect with us

    +1-478-202-3244

    IN +91-120-421-9822

    info@renub.com

    Useful Links

    Latest News